Figure 8. Forest plot for the pooling of odds ratios for incidence of adverse events and for pooling of odds ratios for secondary safety outcomes.

The use of LPV/r was compared with control groups using standard of care or adjuvant therapies without LPV/r. Heterogeneity was quantified using I² statistics. OR < 1 indicates better safety outcomes of LPV/r compared with the control groups for both forest plots. (A) Forest plot for the pooling of ORs for incidence of adverse events. (B) Forest plot for the pooling of ORs for incidence of severe adverse events.

LPV/r: Lopinavir–ritonavir; OR: Odds ratio.